Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68GaNOTA-Anti-MMR-VHH2 for PET Imaging of Tumour-Associated Macrophages in Solid Tumors
NCT04168528Phase 2Terminated
- Sponsor
- UZ Brussel
- Start
- Nov 2019
- Primary completion
- Dec 2024
- Modality
- Nanobodies (VHH)
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-NOTA-anti-MMR VHH2 in malignant solid tumor, breast cancer, melanoma, sponsored by UZ Brussel. Started Nov 2019; status: terminated.
02
Drugs
68Ga-NOTA-anti-MMR VHH2
03
Conditions
malignant solid tumorbreast cancermelanoma
Beyond the preview
Go deeper on NCT04168528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168528.